POLYPEPTIDE N revenue breakdown overview

POLYPEPTIDE N revenue for the last year amounted to 297.71 M CHF, the most of which — 150.06 M CHF — came from its highest performing source at the moment, Custom Projects, the year earlier bringing 140.57 M CHF. The greatest contribution to the revenue figure was made by Europe and Asia — last year it brought POLYPEPTIDE N 221.14 M CHF, and the year before that — 191.54 M CHF.